• AJMCAJMC
  • Center for Biosimilars
Center for Biosimilars®
Center for Biosimilars®
Business Practice
View MoreBusinessDevelopmentLegalPolicyPracticeRegulatory
News
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Compendia
Bone Health
Dermatology
Diabetes
Gastroenterology
Hematology
Neurology
Oncology
Ophthalmology
Rare Disease
Respiratory
Rheumatology
Conferences
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Interactive Tools
Polls
WHEN CHOICE ARRIVES: Competition & Consequences
SubscribeBIOSIMILAR APPROVALS
  • About
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

© 2023 MJH Life Sciences and Center for Biosimilars®. All rights reserved.

Advertisement
Business PracticeSee All >
  • Business
  • Development
  • Legal
  • Policy
  • Practice
  • Regulatory
  • About
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.

Understanding and Improving Access of Biosimilars in Oncology

EP. 1: Biosimilars in Oncology: Addressing Awareness

May 29th 2020

EP. 2: Current State of Biosimilars: Approval, Availability, and Efficacy

May 29th 2020

EP. 3: Biosimilars in Oncology: Equivalency and Cost

May 29th 2020

EP. 4: Are Biosimilar Costs a Factor for Patients?

May 29th 2020

EP. 5: Biosimilars: Addressing Roadblocks to Market Adoption

May 29th 2020

EP. 6: Switching to Available Biosimilars in Oncology

May 29th 2020

EP. 7: Determining Biosimilars' Role in the Formulary

May 29th 2020

EP. 8: Market-Access Considerations for Biosimilars in Oncology

May 29th 2020

EP. 9: Where Do Biosimilars Fit in to the Treatment Landscape?

May 29th 2020

EP. 10: Multiple Biosimilars for a Single-Reference Biologic

May 29th 2020

Advertisement
Advertisement